Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NI-FAPI PET/CT in Solid Tumors
NCT06688305Phase 1Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Aug 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Safety and tolerability at 1 week. Started Aug 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06688305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06688305.